Articles From: PacWest Bancorp Announces Results for the Third Quarter of 2014 to NOVADAQ Appoints Mizuho Medical as PINPOINT Distributor for Japan


Highlights Net Earnings of $62.3 Million or $0.60 Per Diluted Share; Adjusted Net Earnings of $68.4 Million or $0.66 Per Diluted Share Core Net Interest Margin at 5.64% $384.8 Million of Organic Loan and Lease Growth in the Quarter Driven by $974.7 Million of Production Demand Deposits Increased $141.1 Million in the Quarter and are 25% of Total Deposits Core Deposits Increased $268.8 Million in the Quarter and are 52% of Total Deposits LOS ANGELES, Oct.
Sign-up for PacWest Bancorp Announces Results for the Third Quarter of 2014 investment picks
CHICAGO, Oct.
Sign-up for Merge Sets Third Quarter 2014 Earnings Call investment picks
CHICAGO, Oct.
Sign-up for Coeur to Present at Silver Summit investment picks
SUGAR LAND, Texas, Oct.
Sign-up for Fairmount Santrol Continues to Reduce Environmental Footprint at Oklahoma Resin-Coating Plants investment picks
HONG KONG, Oct.
Sign-up for CMGE Granted 12 Character Licenses From Sanrio, Including Hello Kitty investment picks
HONG KONG, Oct.
Sign-up for CMGE to Convene Annual General Meeting investment picks
2014/10/22
KYOTO, Japan, Oct.
Sign-up for Nidec Announces Financial Results for Fiscal Second Quarter and Six Months Ended September 30, 2014 investment picks
LOS ALTOS, Calif., Oct.
Sign-up for DSP Group Delivers HD Voice and Home Automation Utilizing Qualcomm Internet Processor investment picks
VANCOUVER, British Columbia, Oct.
Sign-up for Tekmira Provides Periodic Update on TKM-Ebola Program investment picks
BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) , a global biopharmaceutical company, and Takeda Pharmaceutical Company Limited (Takeda) today announced that on October 17, 2014, they entered into a global license, development, commercialization and supply agreement for AMITIZA ® (lubiprostone). Through this agreement, Takeda expanded its exclusive rights beyond the United States (U.S.) and Canada to further develop and commercialize AMITIZA in all global markets, except Japan and the People's Republic of China.
Sign-up for Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone) investment picks
WESTLAKE VILLAGE, Calif., Oct.
Sign-up for KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program investment picks
Google Chooses Not to Exercise Its Investment Option Himax and Google to Remain Strategic Partners on Google Glass TAINAN, Taiwan, Oct.
Sign-up for Himax Technologies, Inc. Announces Google Inc. Second Round Investment Decision investment picks
STILLWATER, Okla., Oct.
Sign-up for Southwest Bancorp, Inc. Reports Third Quarter 2014 Results and Announces Quarterly Dividend investment picks
NIWOT, Colo., Oct.
Sign-up for Crocs, Inc. Announces Conference Call to Discuss Third Quarter 2014 Results investment picks
Message from our President & CEO Significant progress from the third quarter of 2013: CHAMPAIGN, Ill., Oct.
Sign-up for First Busey Announces 2014 Third Quarter Earnings investment picks
LOWELL, Mass., Oct.
Sign-up for Enterprise Bancorp, Inc. Announces Quarterly Dividend investment picks
MEMPHIS, Tenn., Oct.
Sign-up for Photo Release -- Cecelia D. Stewart Elected to First Horizon Board investment picks
CLEARWATER, Fla., Oct.
Sign-up for Nicholas Financial is Considering Various Financial Initiatives investment picks
MADISON, Wis., Oct.
Sign-up for Cellular Dynamics to Present at the 2014 Medical Innovation Summit investment picks
TORONTO, Oct.
Sign-up for NOVADAQ Appoints Mizuho Medical as PINPOINT Distributor for Japan investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: PacWest Bancorp Announces Results for the Third Quarter of 2014 to NOVADAQ Appoints Mizuho Medical as PINPOINT Distributor for Japan
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent